| 中文名稱:弗洛西單抗 | 英文名稱:Research Grade Frovocimab(DHJ24003) |
| CAS:1643672-70-1 | 純度規(guī)格: PAGE:>95% |
| 產(chǎn)品類別: 藥物對照抗體 | |
| 抗體名: Research Grade Frovocimab(DHJ24003) | 靶點: NARC1, PCSK9 |
| 宿主: Humanized | 適應(yīng)物種: Human |
| 克隆性: Monoclonal | 藥物對照抗體: Research Grade Frovocimab(DHJ24003) |
Catalog No.
DHJ24003
Host species
Humanized
Species reactivity
Human
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Concentration
1 mg/ml
Purity
>95% by SDS-PAGE.
Clonality
Monoclonal
Isotype
IgG4-kappa
Applications
Research Grade Biosimilar
Target
Proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9, NARC-1, PC9, Proprotein convertase 9, Neural apoptosis-regulated convertase 1, NARC1, PCSK9
Purification
Protein A or G purified from cell culture supernatant.
Endotoxin level
Please contact with the lab for this information.
Expression system
XtenCHO
Accession
Q8NBP7
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
Alternative Names
LY-3015014, CAS: 1643672-70-1
Note
For research use only. Not suitable for clinical or therapeutic use.
| 成立日期 | 2021-04-08 (6年) | 注冊資本 | 500萬 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1000萬-5000萬 |
| 主營行業(yè) | 生物化工,技術(shù)服務(wù) | 經(jīng)營模式 | 試劑 |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| ¥2980 |
VIP5年
|
TargetMol中國(陶術(shù)生物)
|
2026-06-29 | |
| ¥669.90 |
VIP3年
|
上海阿拉丁生化科技股份有限公司
|
2026-06-10 | |
| ¥300 |
VIP1年
|
武漢邁思生物科技有限公司
|
2026-06-08 |